Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2C2 ATP2A1 ATP2B1 ATP2B4	5.78e-06	11	235	4	GO:0005388
GeneOntologyCellularComponent	basal plasma membrane	ITGA6 CA14 ADCY8 SLC22A8 AGER ATP2C2 PLEC SLC51A ABCC10 SLC16A6 P2RY6 SLC22A3 ATP2B1 ATP2B4	5.90e-05	354	238	14	GO:0009925
GeneOntologyCellularComponent	basement membrane	LAMA1 ITGA6 FREM2 USH2A FRAS1 LAMA4 LAMB2 FREM3	7.92e-05	122	238	8	GO:0005604
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO1 NOMO3	1.16e-04	9	238	3	GO:0160064
GeneOntologyCellularComponent	basal part of cell	ITGA6 CA14 ADCY8 SLC22A8 AGER ATP2C2 PLEC SLC51A ABCC10 SLC16A6 P2RY6 SLC22A3 ATP2B1 ATP2B4	1.18e-04	378	238	14	GO:0045178
GeneOntologyCellularComponent	basolateral plasma membrane	ITGA6 CA14 ADCY8 SLC22A8 ATP2C2 SLC51A ABCC10 SLC16A6 P2RY6 SLC22A3 ATP2B1 ATP2B4	3.23e-04	320	238	12	GO:0016323
GeneOntologyCellularComponent	laminin-3 complex	LAMA1 LAMB2	3.84e-04	3	238	2	GO:0005608
GeneOntologyCellularComponent	inhibitory synapse	CLCN3 IGSF9 BSN NLGN4Y	4.05e-04	31	238	4	GO:0060077
GeneOntologyCellularComponent	apical part of cell	CDH23 CA14 ADCY8 CLCN3 SLC22A8 AGER PLEC USH2A DUOXA2 SLC26A3 SLC22A12 PLPP1 P2RY6 SLC22A3 PRKG2 SLC5A8 ATP2B1	4.70e-04	592	238	17	GO:0045177
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO2 NOMO1 NOMO3	4.83e-04	14	238	3	GO:0072379
GeneOntologyCellularComponent	apical plasma membrane	CA14 ADCY8 CLCN3 SLC22A8 AGER PLEC USH2A SLC26A3 SLC22A12 PLPP1 P2RY6 SLC22A3 PRKG2 SLC5A8 ATP2B1	4.94e-04	487	238	15	GO:0016324
GeneOntologyCellularComponent	USH2 complex	ADGRV1 USH2A	7.63e-04	4	238	2	GO:1990696
Domain	Calx_beta	ADGRV1 FREM2 FRAS1 FREM3	1.48e-06	8	229	4	SM00237
Domain	Calx_beta	ADGRV1 FREM2 FRAS1 FREM3	2.64e-06	9	229	4	IPR003644
Domain	Calx-beta	ADGRV1 FREM2 FRAS1 FREM3	2.64e-06	9	229	4	PF03160
Domain	DUF2012	NOMO2 NOMO1 NOMO3	7.21e-06	4	229	3	PF09430
Domain	DUF2012	NOMO2 NOMO1 NOMO3	7.21e-06	4	229	3	IPR019008
Domain	Cadherin	CDH26 CDH23 PCDH17 FREM2 PCDHGB3 PCDHA11 FREM3 CDH11 CDHR4	1.50e-05	118	229	9	IPR002126
Domain	EGF_LAM_2	LAMA1 STAB1 USH2A LAMA4 LAMB2	2.94e-05	30	229	5	PS50027
Domain	EGF_LAM_1	LAMA1 STAB1 USH2A LAMA4 LAMB2	2.94e-05	30	229	5	PS01248
Domain	ATPase_P-typ_TM_dom	ATP2C2 ATP2A1 ATP2B1 ATP2B4	3.57e-05	16	229	4	IPR023298
Domain	-	ATP2C2 ATP2A1 ATP2B1 ATP2B4	3.57e-05	16	229	4	1.20.1110.10
Domain	ATPase_P-typ_cation-transptr_C	ATP2C2 ATP2A1 ATP2B1 ATP2B4	4.62e-05	17	229	4	IPR006068
Domain	Cation_ATPase_C	ATP2C2 ATP2A1 ATP2B1 ATP2B4	4.62e-05	17	229	4	PF00689
Domain	Cation_ATPase_N	ATP2C2 ATP2A1 ATP2B1 ATP2B4	5.89e-05	18	229	4	PF00690
Domain	Cation_ATPase_N	ATP2C2 ATP2A1 ATP2B1 ATP2B4	5.89e-05	18	229	4	SM00831
Domain	EGF_Lam	LAMA1 STAB1 USH2A LAMA4 LAMB2	6.38e-05	35	229	5	SM00180
Domain	Laminin_EGF	LAMA1 STAB1 USH2A LAMA4 LAMB2	6.38e-05	35	229	5	PF00053
Domain	ATPase_P-typ_cation-transptr_N	ATP2C2 ATP2A1 ATP2B1 ATP2B4	7.38e-05	19	229	4	IPR004014
Domain	CA	CDH26 CDH23 PCDH17 FREM2 PCDHGB3 PCDHA11 CDH11 CDHR4	8.67e-05	115	229	8	SM00112
Domain	Laminin_EGF	LAMA1 STAB1 USH2A LAMA4 LAMB2	9.57e-05	38	229	5	IPR002049
Domain	Carb-bd-like_fold	NOMO2 NOMO1 NOMO3	9.74e-05	8	229	3	IPR013784
Domain	ATP2B1/4	ATP2B1 ATP2B4	1.50e-04	2	229	2	IPR030319
Domain	ConA-like_dom	LAMA1 ADGRV1 CNTNAP5 USH2A LAMA4 TRIM43 MAMDC4 RSPRY1 TRIM43B RNF39	3.85e-04	219	229	10	IPR013320
Domain	Cadherin_CS	CDH26 CDH23 PCDH17 PCDHGB3 PCDHA11 CDH11 CDHR4	3.93e-04	109	229	7	IPR020894
Domain	Period_circadian-like_C	PER1 PER3	4.45e-04	3	229	2	IPR022728
Domain	Period_C	PER1 PER3	4.45e-04	3	229	2	PF12114
Domain	CarboxyPept_regulatory_dom	NOMO2 NOMO1 NOMO3	4.75e-04	13	229	3	IPR014766
Domain	-	NOMO2 NOMO1 NOMO3	4.75e-04	13	229	3	2.60.40.1120
Domain	CADHERIN_1	CDH26 CDH23 PCDH17 PCDHGB3 PCDHA11 CDH11 CDHR4	4.88e-04	113	229	7	PS00232
Domain	Cadherin	CDH26 CDH23 PCDH17 PCDHGB3 PCDHA11 CDH11 CDHR4	4.88e-04	113	229	7	PF00028
Domain	CADHERIN_2	CDH26 CDH23 PCDH17 PCDHGB3 PCDHA11 CDH11 CDHR4	5.15e-04	114	229	7	PS50268
Domain	-	CDH26 CDH23 PCDH17 PCDHGB3 PCDHA11 CDH11 CDHR4	5.15e-04	114	229	7	2.60.40.60
Domain	Cadherin-like	CDH26 CDH23 PCDH17 PCDHGB3 PCDHA11 CDH11 CDHR4	5.72e-04	116	229	7	IPR015919
Domain	ATPase_P-typ_cyto_domN	ATP2C2 ATP2A1 ATP2B1 ATP2B4	8.55e-04	35	229	4	IPR023299
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B4	8.84e-04	4	229	2	IPR022141
Domain	FAS1	STAB1 POSTN	8.84e-04	4	229	2	SM00554
Domain	FAS1_domain	STAB1 POSTN	8.84e-04	4	229	2	IPR000782
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B4	8.84e-04	4	229	2	PF12424
Domain	Type_II_PanK	PANK2 PANK3	8.84e-04	4	229	2	IPR004567
Domain	Fumble	PANK2 PANK3	8.84e-04	4	229	2	PF03630
Domain	-	STAB1 POSTN	8.84e-04	4	229	2	2.30.180.10
Domain	FAS1	STAB1 POSTN	8.84e-04	4	229	2	PS50213
Domain	Fasciclin	STAB1 POSTN	8.84e-04	4	229	2	PF02469
Domain	P-type_ATPase_IIB	ATP2B1 ATP2B4	8.84e-04	4	229	2	IPR006408
Domain	Laminin_N	LAMA1 USH2A LAMB2	9.05e-04	16	229	3	IPR008211
Domain	LamNT	LAMA1 USH2A LAMB2	9.05e-04	16	229	3	SM00136
Domain	LAMININ_NTER	LAMA1 USH2A LAMB2	9.05e-04	16	229	3	PS51117
Domain	Laminin_N	LAMA1 USH2A LAMB2	9.05e-04	16	229	3	PF00055
Domain	ATPase_P-typ_P_site	ATP2C2 ATP2A1 ATP2B1 ATP2B4	9.53e-04	36	229	4	IPR018303
Domain	P_typ_ATPase	ATP2C2 ATP2A1 ATP2B1 ATP2B4	9.53e-04	36	229	4	IPR001757
Domain	ATPASE_E1_E2	ATP2C2 ATP2A1 ATP2B1 ATP2B4	9.53e-04	36	229	4	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP2C2 ATP2A1 ATP2B1 ATP2B4	1.06e-03	37	229	4	IPR008250
Domain	E1-E2_ATPase	ATP2C2 ATP2A1 ATP2B1 ATP2B4	1.06e-03	37	229	4	PF00122
Domain	CarboxyPept-like_regulatory	NOMO2 NOMO1 NOMO3	1.09e-03	17	229	3	IPR008969
Domain	LAM_G_DOMAIN	LAMA1 CNTNAP5 USH2A LAMA4	1.17e-03	38	229	4	PS50025
Domain	Laminin_G_2	LAMA1 CNTNAP5 USH2A LAMA4	1.42e-03	40	229	4	PF02210
Domain	Laminin_domII	LAMA1 LAMA4	1.46e-03	5	229	2	IPR010307
Domain	Laminin_aI	LAMA1 LAMA4	1.46e-03	5	229	2	IPR009254
Domain	Laminin_I	LAMA1 LAMA4	1.46e-03	5	229	2	PF06008
Domain	Laminin_II	LAMA1 LAMA4	1.46e-03	5	229	2	PF06009
Domain	LamG	LAMA1 CNTNAP5 USH2A LAMA4	2.03e-03	44	229	4	SM00282
Pubmed	Segmental and restricted localization pattern of Fras1 in the developing meningeal basement membrane in mouse.	FREM2 FRAS1 LAMB2 FREM3	2.14e-09	4	238	4	24101214
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	KCTD12 MYO9B TMEM216 PER1 ARHGEF11 MAPK8IP3 GGT7 SARS2 PLEC MMP17 PLXNA1 ABCC10 AGAP3 PRKD2 DPH2 FRAS1 CTC1 DUSP5 HECTD4 LAMB2 GRID1 BTAF1 CFAP43 POM121C ARSG IL17RE PAX2	1.28e-08	1105	238	27	35748872
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO1 NOMO3	3.16e-07	3	238	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO1 NOMO3	3.16e-07	3	238	3	25576386
Pubmed	Expression of Fraser syndrome genes in normal and polycystic murine kidneys.	FREM2 FRAS1 FREM3	3.16e-07	3	238	3	21993971
Pubmed	Differential localization profile of Fras1/Frem proteins in epithelial basement membranes of newborn and adult mice.	FREM2 FRAS1 FREM3	1.26e-06	4	238	3	18563433
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO1 NOMO3	1.26e-06	4	238	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO1 NOMO3	1.26e-06	4	238	3	9267806
Pubmed	The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut.	LAMA1 ITGA6 LAMA4 LAMB2	1.46e-06	13	238	4	36350252
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	LAMA1 FREM2 FRAS1 LAMB2 PAX2	1.49e-06	29	238	5	22613833
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	KCTD13 MAPK8IP3 STAB1 ASB8 IGSF9 AGAP3 ATN1 GPS1 NCKIPSD PLEKHA4 LAMB2 MAGI3 TRIM3 NOMO1 COIL RBFOX2	1.87e-06	560	238	16	21653829
Pubmed	Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development.	FREM2 FRAS1 FREM3	3.13e-06	5	238	3	17251066
Pubmed	Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.	FREM2 FRAS1 FREM3	3.13e-06	5	238	3	17596926
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	LAMA1 ITGA6 LAMA4 LAMB2	3.65e-06	16	238	4	17948866
Pubmed	Molecular characterization of the ankle-link complex in cochlear hair cells and its role in the hair bundle functioning.	CDH23 ADGRV1 ADCY8 USH2A	3.65e-06	16	238	4	17567809
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	LAMA1 ITGA6 LAMA4 LAMB2	3.65e-06	16	238	4	17601529
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	ARHGEF11 PHKB NOMO2 PLEC DIP2B PRPF8 YARS1 NOMO1 UBASH3B PCBP2 NOMO3 ATP5F1B	5.13e-06	344	238	12	30333137
Pubmed	A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1.	LAMA1 FREM2 FRAS1 FREM3	6.07e-06	18	238	4	14730302
Pubmed	Frem3, a member of the 12 CSPG repeats-containing extracellular matrix protein family, is a basement membrane protein with tissue distribution patterns distinct from those of Fras1, Frem2, and QBRICK/Frem1.	FREM2 FRAS1 FREM3	6.23e-06	6	238	3	17462874
Pubmed	Genomic analysis of mouse retinal development.	CHGA STAB1 NOMO2 IGSF9 PLEC BSN DYRK2 LRIT2 PANK3 DUSP5 GPS1 SEMA4G ARSG NOMO1 LIMK2 ZFHX4 UNC5C PRKAR2A UBASH3B CDH11 NOMO3	6.77e-06	1006	238	21	15226823
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DDX3X POLR1F PANK2 FAM83G MIEF1 PLEC PLEKHA7 TNS3 DYRK2 AGAP3 DIP2B PANK3 NCKIPSD MAGI3 INPP5F LRPPRC TBC1D10B LIMK2 ATP2B1	8.73e-06	861	238	19	36931259
Pubmed	Laminin and integrin expression in the ventral ectodermal ridge of the mouse embryo: implications for regulation of BMP signalling.	LAMA1 ITGA6 LAMA4 LAMB2	9.51e-06	20	238	4	22911573
Pubmed	Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.	CDH23 ADGRV1 USH2A	1.09e-05	7	238	3	20058854
Pubmed	Laminin isoforms in fetal and adult human adrenal cortex.	LAMA1 LAMA4 LAMB2	1.09e-05	7	238	3	14557481
Pubmed	BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.	ZNF318 DDX3X PLEC TNS3 PRPF8 SF1 PCBP2 ATP5F1B	1.30e-05	156	238	8	32850835
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	ARSK CDH23 CA14 TMEM52B FAM3D ATP2C2 IGSF9 FLRT2 BCAR3 DNHD1 MAMDC4 RSPRY1 SLC22A12 ARSG PPIF LRP10 IL17RE LRRC8B LGR6 CDHR4	1.68e-05	985	238	20	12975309
Pubmed	Microarray-based mutation analysis of 183 Spanish families with Usher syndrome.	CDH23 ADGRV1 USH2A	1.73e-05	8	238	3	19683999
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO2 NOMO1 NOMO3	1.73e-05	8	238	3	15257293
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2A1 ATP2B1 ATP2B4	1.73e-05	8	238	3	10951186
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO2 NOMO1 NOMO3	2.58e-05	9	238	3	36261522
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	FLRT2 PLXNA1 PLXNB1 SEMA4G UNC5C	2.88e-05	52	238	5	26633812
Pubmed	Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.	CDH23 ADGRV1 USH2A	3.66e-05	10	238	3	24618850
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	FREM2 FRAS1 FREM3	3.66e-05	10	238	3	15345741
Pubmed	Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro.	LAMA1 ITGA6 LAMA4	3.66e-05	10	238	3	18590826
Pubmed	Trophoblast-specific expression and function of the integrin alpha 7 subunit in the peri-implantation mouse embryo.	LAMA1 ITGA6 LAMA4	3.66e-05	10	238	3	11784026
Pubmed	Usher protein functions in hair cells and photoreceptors.	CDH23 ADGRV1 USH2A	3.66e-05	10	238	3	24239741
Pubmed	Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons.	LAMA1 LAMA4 LAMB2	3.66e-05	10	238	3	9034910
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RABEP2 KCTD12 CTTNBP2 ZNF318 ARHGEF11 TMEM132B DDX3X MAPK8IP3 CNTNAP5 BSN DIP2B CACNB1 HECTD4 TRIM3 LRPPRC PRKAR2A UBASH3B ATP2B4 CDH11	4.04e-05	963	238	19	28671696
Pubmed	Biology, structure and mechanism of P-type ATPases.	ATP2C2 ATP2A1 ATP2B1 ATP2B4	4.44e-05	29	238	4	15071553
Pubmed	Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cells.	CHGA PRKD2	4.66e-05	2	238	2	18262756
Pubmed	Functional and structural demonstration of the presence of Ca-ATPase (PMCA) in both microvillous and basal plasma membranes from syncytiotrophoblast of human term placenta.	ATP2B1 ATP2B4	4.66e-05	2	238	2	18657858
Pubmed	Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis.	FREM2 FRAS1	4.66e-05	2	238	2	21900877
Pubmed	Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding.	ITGA6 PLEC	4.66e-05	2	238	2	10525545
Pubmed	Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex.	PPIF ATP5F1B	4.66e-05	2	238	2	19801635
Pubmed	Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.	LAMA4 LAMB2	4.66e-05	2	238	2	19048114
Pubmed	The serum protein renalase reduces injury in experimental pancreatitis.	RNLS ATP2B4	4.66e-05	2	238	2	29042438
Pubmed	Plexin-A1 and plexin-B1 specifically interact at their cytoplasmic domains.	PLXNA1 PLXNB1	4.66e-05	2	238	2	12559962
Pubmed	Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome.	PER1 PER3	4.66e-05	2	238	2	11306557
Pubmed	Selective down-regulation of the alpha6-integrin subunit in melanocytes by UVB light.	LAMA1 ITGA6	4.66e-05	2	238	2	15885076
Pubmed	Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4.	ATP2B1 ATP2B4	4.66e-05	2	238	2	15178683
Pubmed	Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis.	ITGA6 LAMA4	4.66e-05	2	238	2	25218639
Pubmed	Molecular study of 33 families with Fraser syndrome new data and mutation review.	FREM2 FRAS1	4.66e-05	2	238	2	18671281
Pubmed	Nuclear import of mPER3 in Xenopus oocytes and HeLa cells requires complex formation with mPER1.	PER1 PER3	4.66e-05	2	238	2	16008569
Pubmed	Novel loss of function variants in FRAS1 AND FREM2 underlie renal agenesis in consanguineous families.	FREM2 FRAS1	4.66e-05	2	238	2	32643034
Pubmed	Sarco(endo)plasmic reticulum and plasmalemmal Ca(2+)-ATPase activities in cremaster muscles and sacs differ according to the associated inguinal pathology.	ATP2A1 ATP2B1	4.66e-05	2	238	2	16933204
Pubmed	Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets.	ATP2B1 ATP2B4	4.66e-05	2	238	2	10748016
Pubmed	Laminin, a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains.	LAMA1 LAMB2	4.66e-05	2	238	2	3182802
Pubmed	SF-1 (NR5A1) expression is stimulated by the PKA pathway and is essential for the PKA-induced activation of LIPE expression in Y-1 cells.	SF1 LIPE	4.66e-05	2	238	2	26122391
Pubmed	Dual-specificity phosphatase (DUSP) genetic variants predict pulmonary hypertension in patients with bronchopulmonary dysplasia.	DUSP1 DUSP5	4.66e-05	2	238	2	31330530
Pubmed	Renalase and its receptor, PMCA4b, are expressed in the placenta throughout the human gestation.	RNLS ATP2B4	4.66e-05	2	238	2	35322081
Pubmed	Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells.	CDH23 USH2A	4.66e-05	2	238	2	17360538
Pubmed	Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival.	ATP2B1 ATP2B4	4.66e-05	2	238	2	23266958
Pubmed	Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype.	ADGRV1 USH2A	4.66e-05	2	238	2	15671307
Pubmed	Structural and functional analysis of the actin binding domain of plectin suggests alternative mechanisms for binding to F-actin and integrin beta4.	ITGA6 PLEC	4.66e-05	2	238	2	12791251
Pubmed	Characteristics of Retinitis Pigmentosa Associated with ADGRV1 and Comparison with USH2A in Patients from a Multicentric Usher Syndrome Study Treatrush.	ADGRV1 USH2A	4.66e-05	2	238	2	34638692
Pubmed	PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells.	PER1 PER3	4.66e-05	2	238	2	21459569
Pubmed	Acidic glycosaminoglycans and laminin-1 in renal corpuscles of mutant blebs (my) and control mice.	LAMA1 FREM2	4.66e-05	2	238	2	9302549
Pubmed	Distribution of alpha 6 integrin subunit in developing mouse submandibular gland.	LAMA1 ITGA6	4.66e-05	2	238	2	8409377
Pubmed	PAX3 promotes tumor progression via CD105 signaling.	PAX3 ENG	4.66e-05	2	238	2	23274166
Pubmed	Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation.	ADGRV1 USH2A	4.66e-05	2	238	2	28653555
Pubmed	The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity.	ATP2B1 ATP2B4	4.66e-05	2	238	2	16412504
Pubmed	Distinct roles of PMCA isoforms in Ca2+ homeostasis of bladder smooth muscle: evidence from PMCA gene-ablated mice.	ATP2B1 ATP2B4	4.66e-05	2	238	2	16956963
Pubmed	Localization of two genes encoding plasma membrane Ca2(+)-transporting ATPases to human chromosomes 1q25-32 and 12q21-23.	ATP2B1 ATP2B4	4.66e-05	2	238	2	1674727
Pubmed	Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility.	PLXNA1 PLXNB1	4.66e-05	2	238	2	14734633
Pubmed	Role of plasma membrane Ca2+-ATPase in contraction-relaxation processes of the bladder: evidence from PMCA gene-ablated mice.	ATP2B1 ATP2B4	4.66e-05	2	238	2	16291816
Pubmed	Selective upregulation of the expression of plasma membrane calcium ATPase isoforms upon differentiation and 1,25(OH)2D3-vitamin treatment of colon cancer cells.	ATP2B1 ATP2B4	4.66e-05	2	238	2	26116539
Pubmed	Polymorphisms in period genes and bone response to hormone therapy in postmenopausal Korean women.	PER1 PER3	4.66e-05	2	238	2	26624862
Pubmed	Identification of a receptor for extracellular renalase.	RNLS ATP2B4	4.66e-05	2	238	2	25906147
Pubmed	The Mass1frings mutation underlies early onset hearing impairment in BUB/BnJ mice, a model for the auditory pathology of Usher syndrome IIC.	CDH23 ADGRV1	4.66e-05	2	238	2	15820310
Pubmed	Investigation of the association between ATP2B4 and ATP5B genes with colorectal cancer.	ATP2B4 ATP5F1B	4.66e-05	2	238	2	24583174
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	A2M KCTD12 GGT7 ALDH9A1 QKI TNS3 PRKD2 DIP2B DUSP1 DUSP5 GPS1 LAMB2 FUOM PRPF8 NOMO1 LRPPRC ATP2A1 ATP2B1 ATP5F1B	4.70e-05	974	238	19	28675297
Pubmed	Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.	LAMA1 LAMA4 LAMB2	5.01e-05	11	238	3	23472759
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO2 NOMO1 NOMO3	5.01e-05	11	238	3	32820719
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMA1 LAMA4 LAMB2	5.01e-05	11	238	3	21524702
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	TUBB4A NOMO2 NOMO1 NOMO3	5.82e-05	31	238	4	19136429
Pubmed	Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis.	LAMA1 ITGA6 LAMA4	6.65e-05	12	238	3	11381080
Pubmed	Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles.	LAMA1 ITGA6 LAMA4	6.65e-05	12	238	3	12843252
Pubmed	Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.	LAMA1 LAMA4 LAMB2	6.65e-05	12	238	3	9396756
Pubmed	Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population.	STAB1 BSN PLXNB1 LAMB2 PRKAR2A	6.78e-05	62	238	5	19367581
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	LAMA1 FRAS1 LAMA4 LAMB2 FREM3	7.90e-05	64	238	5	22261194
Pubmed	Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa.	SLC22A8 SLC22A12 SLC22A3	8.60e-05	13	238	3	15369770
Pubmed	Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin beta4 cytoplasmic domain.	ITGA6 PLEC LAMB2	8.60e-05	13	238	3	9670011
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	PCDH17 KLHL42 SLC51A DMPK QKI CACNB1 GCFC2 ATN1 NOMO1 ENTPD6 COIL PCBP2 NOMO3 RBFOX2	8.72e-05	608	238	14	16713569
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	KCTD12 ARSK LAMA1 ITGA6 HM13 GGT7 LMF2 NOMO2 PLXNA1 PLXNB1 FRAS1 GPS1 LAMA4 LAMB2 NOMO1 LRP10 SLC22A3 ENTPD6 ENG ATP2B1 ATP5F1B	8.91e-05	1201	238	21	35696571
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	A2M DDX3X TUBB4A LMF2 NOMO2 PLXNA1 GPS1 LAMB2 PRPF8 NOMO1 LRPPRC PCBP2 NOMO3 ATP5F1B	9.50e-05	613	238	14	22268729
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CDH26 DGKH ADGRV1 HM13 MAPK8IP3 PHKB IGSF9 PRKAG2 ZSWIM4 AGAP1 AGAP3 DIP2B NLGN4Y HECTD4 MAGI3 BTAF1 LRPPRC TRNT1 TESMIN PLPP1 SLC22A3 NAXD ATP2B1 RBFOX2	9.77e-05	1489	238	24	28611215
Pubmed	Sall1 balances self-renewal and differentiation of renal progenitor cells.	RNF128 FRAS1 LAMA4 POSTN PAX2	9.84e-05	67	238	5	24550112
Pubmed	Sonic hedgehog-dependent synthesis of laminin alpha1 controls basement membrane assembly in the myotome.	LAMA1 ITGA6 PAX3	1.09e-04	14	238	3	19783738
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	CACNB1 ATP2A1 ATP2B1 ATP2B4	1.31e-04	38	238	4	30786075
Pubmed	Sprouty1 haploinsufficiency prevents renal agenesis in a model of Fraser syndrome.	FREM2 FRAS1 PAX2	1.35e-04	15	238	3	23064016
GeneFamily	ATPases Ca2+ transporting	ATP2C2 ATP2A1 ATP2B1 ATP2B4	5.70e-07	9	151	4	1209
GeneFamily	Laminin subunits	LAMA1 LAMA4 LAMB2	1.19e-04	12	151	3	626
GeneFamily	Fibronectin type III domain containing\|USH2 complex	ADGRV1 USH2A	4.11e-04	4	151	2	1244
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DGKH PLEKHA7 AGAP1 AGAP3 PRKD2 PLEKHA4 PSD4	1.74e-03	206	151	7	682
GeneFamily	Paired boxes	PAX2 PAX3	2.40e-03	9	151	2	675
GeneFamily	Plexins	PLXNA1 PLXNB1	2.40e-03	9	151	2	683
Coexpression	NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	MYO9B CSMD3 DYRK2 PPM1E DGKE ZFHX4 TESMIN MSLNL	2.26e-06	94	237	8	M18108
Coexpression	JI_RESPONSE_TO_FSH_DN	ITGA6 DDX3X PLEC PANK3 DUSP1 CCNF	8.25e-06	53	237	6	M17537
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KCTD12 ADGRV1 CSMD3 STAB1 FAM186A FLRT2 PLEC USH2A HDAC10 CDH11	6.73e-08	186	238	10	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDH26 ADGRV1 PLEKHA7 AGAP1 FRAS1 MAGI3 ERN2 P2RY6 SLC22A3 RNF39	1.21e-07	198	238	10	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M MFAP2 RNF128 TNS3 FRAS1 LAMA4 LAMB2 ZFHX4 UNC5C CDH11	1.33e-07	200	238	10	ad3fb8ef0be45032369d1325024787fbe1dfb8d6
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHGA ADGRV1 CSMD3 ADCY8 CIITA BCAR3 USH2A FRAS1 ZFHX4	4.48e-07	175	238	9	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 LAMA1 ADGRV1 ADCY8 ATP2C2 TNS3 FRAS1 PAX2 UBASH3B	5.95e-07	181	238	9	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	RNLS CFAP54 CFAP206 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	6.23e-07	182	238	9	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CAPN12 AMACR ADGRV1 FAM3D ADCY8 USH2A SLC22A12 SLC5A8 ACMSD	6.52e-07	183	238	9	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	PND01-03-samps-Mesenchymal-Pericyte-pericyte_E\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	CHGA ADCY8 TUBB4A SLC22A8 NAALAD2 SEMA4G POSTN DNAI7	6.78e-07	135	238	8	35928195cf34f055b353562c96f451aef2344d64
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M LAMA1 ADGRV1 CSMD3 FREM2 USH2A FRAS1 GRID1 ZFHX4	6.82e-07	184	238	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M LAMA1 ADGRV1 CSMD3 FREM2 USH2A FRAS1 GRID1 ZFHX4	6.82e-07	184	238	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M LAMA1 ADGRV1 CSMD3 FREM2 USH2A FRAS1 GRID1 ZFHX4	6.82e-07	184	238	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEXMIF STAB1 DUOXA2 DOK7 APBA2 LAMA4 SAPCD1 SNED1 ATP2B4	8.17e-07	188	238	9	a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c
ToppCell	droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEXMIF STAB1 DUOXA2 DOK7 APBA2 LAMA4 SAPCD1 SNED1 ATP2B4	8.17e-07	188	238	9	54550313db78b3b5b572fa1e67092c8f6f33aab5
ToppCell	Control\|World / Disease state, Lineage and Cell class	MYO9B CDH23 TMEM52B STAB1 BCAR3 QKI PPIF ENG ATP2B1	8.54e-07	189	238	9	fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CTTNBP2 CSMD3 FRAS1 NAALAD2 NLGN4Y LAMA4 PLPP1 UNC5C CDH11	8.54e-07	189	238	9	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 ADCY8 FREM2 ATP2C2 FRAS1 MAGI3 IL17RE SLC22A3 PRKG2	8.92e-07	190	238	9	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 FREM2 PLEKHA7 PLXNB1 TNS3 NWD1 LAMB2 ZFHX4	8.92e-07	190	238	9	5c64b727669b23d2a23c8ad1d5d6caab7af37d56
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	CDH26 NEXMIF ADGRV1 FAM3D ATP2C2 PLEKHA7 AGAP1 ERN2 CATSPERB	8.92e-07	190	238	9	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	3'_v3-blood-Lymphocytic_Invariant-Inducer-like-MAIT\|blood / Manually curated celltypes from each tissue	A2M CAPN12 CSMD3 AGAP1 DUSP1 PPM1E MAMDC4 RORC	9.94e-07	142	238	8	1175d4390d204ffa3a2d2fe24486f85d3b639b72
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	CDH26 NEXMIF ADGRV1 AGAP1 FRAS1 MAGI3 ERN2 SLC22A3 RNF39	1.02e-06	193	238	9	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADGRV1 CFAP54 ATP2C2 CFAP47 NWD1 PLEKHA4 CFAP43 CDHR4 CFAP157	1.02e-06	193	238	9	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	RNLS AK9 CFAP54 CFAP206 CFAP47 NWD1 CFAP43 DNAI7 CDHR4	1.02e-06	193	238	9	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	Endothelial\|World / shred by cell class for bronchial biopsy	A2M KCTD12 ITGA6 STAB1 FLRT2 LAMA4 BCL6B POSTN ENG	1.11e-06	195	238	9	f0e46e859f7a9bdead3203889f7e20fa21f76ff0
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	LAMA1 CDH23 ADGRV1 TMEM132B NBPF19 QKI PLEKHA7 LAMB2 ZFHX4	1.20e-06	197	238	9	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	LAMA1 CDH23 ADGRV1 TMEM132B NBPF19 QKI PLEKHA7 LAMB2 ZFHX4	1.20e-06	197	238	9	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDH26 ADGRV1 PLEKHA7 AGAP1 FRAS1 MAGI3 ERN2 P2RY6 RNF39	1.26e-06	198	238	9	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ITGA6 CDH23 METTL1 FREM2 FES SLC51A WAS FUOM P2RY6	1.37e-06	200	238	9	be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866
ToppCell	3'_v3-blood-Lymphocytic_Invariant-Inducer-like\|blood / Manually curated celltypes from each tissue	A2M CAPN12 CDH26 CYP21A2 CSMD3 DUSP1 PPM1E RORC	1.43e-06	149	238	8	75422e1a22736375e9ef439db0b2a5efa3f653a3
ToppCell	PND01-03-samps-Mesenchymal-Pericyte\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	CA14 CHGA ADCY8 TUBB4A MMP17 NAALAD2 SEMA4G POSTN	1.66e-06	152	238	8	fc9472bc19f997103da535b035105f01429cb08e
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	ANO9 HOGA1 ATP2C2 PLXNB1 CFAP47 CFAP43 CDHR4 CFAP157	2.02e-06	156	238	8	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 LAMA1 ADGRV1 ADCY8 USH2A FRAS1 ZFHX4 UNC5C	2.44e-06	160	238	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 LAMA1 ADGRV1 ADCY8 USH2A FRAS1 ZFHX4 UNC5C	2.44e-06	160	238	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FAM186A FREM3 MAMDC4 UBAP1L SLC5A8 PSD4	2.60e-06	73	238	6	cc89c94a3768b02036757dea86989d9284b214b9
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FAM186A FREM3 MAMDC4 UBAP1L SLC5A8 PSD4	2.60e-06	73	238	6	6f28d52700bab981c8a3664ba4762f3572f7e788
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FAM186A FREM3 MAMDC4 UBAP1L SLC5A8 PSD4	2.60e-06	73	238	6	ae80fcf3544c18fe0318a8311e96f2448f7cb03c
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADGRV1 CSMD3 FREM2 CNTNAP5 USH2A FRAS1 SLC26A3 LGR6	2.67e-06	162	238	8	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CAPN12 CA14 PCDH17 LMF2 CIITA DYRK2 PRKD2 BCL6B	2.80e-06	163	238	8	7864e966c228282b4b63c43164dba3faba21026d
ToppCell	LPS_only-Epithelial_airway-Club_cells-Airway\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDH26 FAM3D FREM2 DUOXA2 CFAP43 SLC22A3 SLC5A8 RNF39	2.93e-06	164	238	8	b1243b10591e1e15a94952e39ffbf382eae6aae8
ToppCell	LPS_only-Epithelial_airway-Club_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDH26 FAM3D FREM2 DUOXA2 CFAP43 SLC22A3 SLC5A8 RNF39	2.93e-06	164	238	8	c5b2001280a43da855017361a3f6071a0e492848
ToppCell	Ciliated_cells-B-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	PCDH17 CFAP54 CFAP206 CFAP47 CFAP43 ERN2 CDHR4 CFAP157	3.20e-06	166	238	8	4b1056aad8a99827835242b8ab0c7f2bb84471f1
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	CFAP54 PLEKHA7 CFAP47 NWD1 CFAP43 LGR6 DNAI7 PSD4	3.99e-06	171	238	8	74be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FREM2 AGER AGAP3 ASPG MAGI3 SLC22A3 PRKG2	4.54e-06	174	238	8	2cd6638b361ca05ab83d09ce657194aed97873b7
ToppCell	facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 NWD1 APBA2 LAMA4 SAPCD1 PAX2 RNF39 ATP2B4	4.94e-06	176	238	8	057d2759fdc67176c25802b57a78064d8cc93205
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB1 NWD1 APBA2 LAMA4 SAPCD1 PAX2 RNF39 ATP2B4	4.94e-06	176	238	8	b81e5d23b31cefc8d374ef403e21acc390c14a80
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CDH26 CTTNBP2 PCDH17 LAMA4 BCL6B PLPP1 SLC5A8 ENG	5.15e-06	177	238	8	6da88c358b3a2e47fa3472217a38b6b00ad7b280
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFAP54 CFAP47 NWD1 PPM1E CFAP43 DNAI7 CDHR4 CFAP157	5.37e-06	178	238	8	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDH26 DGKH ADGRV1 ATP2C2 DUSP5 ERN2 CATSPERB SLC5A8	5.59e-06	179	238	8	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDH26 NEXMIF ADGRV1 FRAS1 MAGI3 ERN2 SLC22A3 RNF39	5.82e-06	180	238	8	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STAB1 DUOXA2 APBA2 LAMA4 SNED1 PAX2 RNF39 ATP2B4	6.32e-06	182	238	8	2cc434e46985c66fc36de05344a67aa96d90abc9
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STAB1 DUOXA2 APBA2 LAMA4 SNED1 PAX2 RNF39 ATP2B4	6.32e-06	182	238	8	0cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 LAMA1 ADGRV1 ATP2C2 TNS3 FRAS1 PAX2 UBASH3B	6.32e-06	182	238	8	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STAB1 DUOXA2 APBA2 LAMA4 SNED1 PAX2 RNF39 ATP2B4	6.32e-06	182	238	8	3e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPZ2 PTGER4 ATP2C2 TRMO ERN2 ARSG SLC16A6 IRGC	6.58e-06	183	238	8	5a936fb07074cec753bf19e3e3e52499605ea22c
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPZ2 PTGER4 ATP2C2 TRMO ERN2 ARSG SLC16A6 IRGC	6.58e-06	183	238	8	07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP54 CFAP47 NWD1 PPM1E CFAP43 DNAI7 CDHR4 CFAP157	6.84e-06	184	238	8	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	CFAP54 CFAP206 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	7.12e-06	185	238	8	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 CFAP206 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	7.12e-06	185	238	8	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	CFAP54 CFAP47 NWD1 PPM1E CFAP43 DNAI7 CDHR4 CFAP157	7.12e-06	185	238	8	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 FREM2 CFAP54 IGSF9 CFAP43 PAX2 DNAI7 UBASH3B	7.41e-06	186	238	8	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP54 CFAP206 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	7.41e-06	186	238	8	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	CFAP54 CFAP206 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	7.41e-06	186	238	8	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	PCW_05-06-Neuronal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ITGA6 CHGA ADGRV1 TMEM132B PCDH17 MMP17 POSTN DLL3	7.70e-06	187	238	8	03a2ed85b171c887d4f3b0f4fe2e1cb4a853e658
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 AGER FRAS1 ASPG DUSP1 MAGI3 FREM3 PRKG2	7.70e-06	187	238	8	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M MFAP2 FLRT2 MMP17 F2RL3 LAMA4 BCL6B ENG	8.01e-06	188	238	8	26915db8863f4115b46a81982e187322e21600fd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M MFAP2 FLRT2 MMP17 F2RL3 LAMA4 BCL6B ENG	8.01e-06	188	238	8	61ee7b152745164293d8a44ef91ee2393efbdca5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M MFAP2 FLRT2 MMP17 F2RL3 LAMA4 BCL6B ENG	8.01e-06	188	238	8	3f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFAP54 CFAP47 NWD1 PPM1E CFAP43 DNAI7 CDHR4 CFAP157	8.01e-06	188	238	8	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CFAP54 CFAP206 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	8.33e-06	189	238	8	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	RNLS AK9 CFAP54 CFAP47 NWD1 CFAP43 DNAI7 CDHR4	8.33e-06	189	238	8	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LAMA1 ITGA6 ADGRV1 ADCY8 FREM2 CFAP54 ATP2C2 FRAS1	8.65e-06	190	238	8	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COPZ2 MFAP2 FRAS1 LAMA4 LAMB2 ZFHX4 PNMA8A RBFOX2	8.65e-06	190	238	8	20106e5213f6a7560554b8b4f84b23c5554ba975
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NEXMIF STAB1 FLRT2 DUOXA2 APBA2 LAMA4 LAMB2 POSTN	8.65e-06	190	238	8	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NEXMIF STAB1 FLRT2 DUOXA2 APBA2 LAMA4 LAMB2 POSTN	8.65e-06	190	238	8	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COPZ2 MFAP2 FRAS1 LAMA4 LAMB2 ZFHX4 PNMA8A RBFOX2	8.65e-06	190	238	8	877b544decf302e0d41be23dffa1861f79c70914
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STAB1 DUOXA2 DOK7 APBA2 LAMA4 SAPCD1 SNED1 ATP2B4	8.65e-06	190	238	8	e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STAB1 DUOXA2 DOK7 APBA2 LAMA4 SAPCD1 SNED1 ATP2B4	8.65e-06	190	238	8	f32d66c0e74e0a2a23ecb857c4daf0d8573a806c
ToppCell	10x5'v1-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COPZ2 MFAP2 FRAS1 LAMA4 LAMB2 ZFHX4 PNMA8A RBFOX2	8.65e-06	190	238	8	81f8f2cddf4c51b879f315260cd1fca80355a371
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STAB1 DUOXA2 DOK7 APBA2 LAMA4 SAPCD1 SNED1 ATP2B4	8.65e-06	190	238	8	b79ffd05806244a9790cd04c66fb4f92c824e69f
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NEXMIF STAB1 FLRT2 DUOXA2 APBA2 LAMA4 LAMB2 POSTN	8.65e-06	190	238	8	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	Substantia_nigra-Macroglia-CSF_related\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CDH26 AK9 CFAP206 SLC26A3 SLC5A8 CDHR4 CFAP157	8.68e-06	136	238	7	47663c5d81c766a333207a44fc5b58b07309ee76
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CDH26 AK9 CFAP206 SLC26A3 SLC5A8 CDHR4 CFAP157	8.68e-06	136	238	7	6d2e5b871f4cf8d64e6fe0be666fb3490797c635
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CDH26 AK9 CFAP206 SLC26A3 SLC5A8 CDHR4 CFAP157	8.68e-06	136	238	7	fd4269d194c7c11c6ab4383393a01efab05cbace
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CDH26 AK9 CFAP206 SLC26A3 SLC5A8 CDHR4 CFAP157	8.68e-06	136	238	7	3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b
ToppCell	Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CDH26 AK9 CFAP206 SLC26A3 SLC5A8 CDHR4 CFAP157	8.68e-06	136	238	7	67d736096d6b6ddb4722809557f5e987063b8d23
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 LAMA1 DGKH CFAP54 TNS3 CFAP43 PAX2 UBASH3B	8.99e-06	191	238	8	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	ATP2C2 PLXNB1 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	8.99e-06	191	238	8	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RNLS CFAP54 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	8.99e-06	191	238	8	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RNLS CFAP54 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	8.99e-06	191	238	8	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RNLS CFAP54 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	8.99e-06	191	238	8	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	A2M ITGA6 CDH23 PCDH17 PRKD2 POSTN PLPP1 ENG	8.99e-06	191	238	8	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	ATP2C2 PLXNB1 CFAP47 NWD1 CFAP43 DNAI7 CDHR4 CFAP157	8.99e-06	191	238	8	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M STAB1 FLRT2 TRIM43 TRIM43B ENG ATP2B4 CDH11	9.34e-06	192	238	8	0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 PLEKHA7 PLXNB1 TNS3 NWD1 LAMB2 ZFHX4	9.34e-06	192	238	8	705ce805cb00a53793b57bcf466d0fbec590a83c
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 PLEKHA7 PLXNB1 TNS3 NWD1 LAMB2 ZFHX4	9.34e-06	192	238	8	f7e4509003d71f805b9d4587098e90d2897b6739
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 PLEKHA7 PLXNB1 TNS3 NWD1 LAMB2 ZFHX4	9.34e-06	192	238	8	43beaac1de99b9c1a6dab4a450b4e81286987b64
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	RNLS AK9 CFAP54 CFAP47 NWD1 CFAP43 DNAI7 CDHR4	9.70e-06	193	238	8	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 PLEKHA7 PLXNB1 TNS3 NWD1 LAMB2 ZFHX4	9.70e-06	193	238	8	40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA1 ADGRV1 PLEKHA7 PLXNB1 TNS3 NWD1 LAMB2 ZFHX4	9.70e-06	193	238	8	b03d908d4b8940927f72c76a1b0f237d13f39056
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPZ2 PTGER4 CLPS ATP2C2 DUSP5 ERN2 PLPP1 RNF39	9.70e-06	193	238	8	4aee372ba2c0351b0221d0d468707d1ad21526d6
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPZ2 PTGER4 CLPS ATP2C2 DUSP5 ERN2 PLPP1 RNF39	9.70e-06	193	238	8	aaa5042388dc451bff384c6bb237348f08280a08
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A	PER1 ARHGEF11 PCDH17 FASTK FLRT2 CACNB1 HNF1A GCFC2 WAS DUSP1 ZFHX4 PAX2 PSD4	1.02e-07	191	235	13	2955_UP
Drug	I-Q-S	CYP21A2 LAMA1 ADCY8 DMPK PRKD2 LAMA4 LAMB2 PRKAR2A PRKG2 ATP2A1 ATP5F1B	7.01e-07	156	235	11	CID000003540
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	MRS2 DDX3X PER3 PLEC CHAC1 GCFC2 PPM1E BAZ1B TRIM3 PPIF P2RY6 RBFOX2	7.51e-07	191	235	12	1023_DN
Drug	1sqc	ATP2C2 ATP2A1 ATP2B1 ATP2B4	2.21e-06	10	235	4	CID000444279
Drug	2,5-dimethylquinone	ATP2C2 ATP2A1 ATP2B1 ATP2B4	3.45e-06	11	235	4	CID000008718
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; HL60; HG-U133A	MYO9B PER1 FASTK PLEC TNS3 DYRK2 DUSP1 TRMO CCNF RBFOX2 PSD4	4.82e-06	190	235	11	1396_UP
Drug	Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A	PER1 PCDH17 MAPK8IP3 CLCN3 CIITA PLEC DMPK CHAC1 CACNB1 TESMIN ATP2B4	4.82e-06	190	235	11	4155_UP
Drug	1vyq	ATP2C2 ATP2A1 ATP2B1 ATP2B4	5.13e-06	12	235	4	CID004369390
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	MAPK8IP3 METTL1 FASTK FES PLEC ABCC10 DPH2 GCFC2 ERN2 SF1 P2RY6	5.60e-06	193	235	11	2904_DN
Drug	rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; MCF7; HT_HG-U133A	RABEP2 MYO9B PER1 MAPK8IP3 LMF2 APBA2 LAMA4 PRKAR2A RORC PAX2 ATP2A1	7.50e-06	199	235	11	5975_DN
Drug	agelasine B	CHGA ATP2C2 PRKD2 ATP2A1 ATP2B1 ATP2B4	7.52e-06	46	235	6	CID006439899
Drug	Pyrethroids	CHGA ATP2C2 DMPK QKI ATP2A1 ATP2B1 ATP2B4	8.66e-06	71	235	7	CID000005053
Drug	p-hydroxyhippuric acid	ATP2C2 ATP2A1 ATP2B1 ATP2B4	1.02e-05	14	235	4	CID000151012
Drug	AC1L88YH	ATP2C2 ATP2A1 ATP2B1 ATP2B4	2.37e-05	17	235	4	CID000374551
Drug	Bay K 8644	ADCY8 ATP2C2 DMPK PRKD2 CACNB1 PRKAR2A ATP2A1 ATP2B1 ATP2B4	2.68e-05	150	235	9	CID000002303
Drug	CC270	LAMA1 CA14 DMPK LAMA4 LAMB2 ATP2A1	3.24e-05	59	235	6	CID006918852
Drug	LG 5	LAMA1 ITGA6 ATN1 LAMA4 LAMB2 PPIF	3.56e-05	60	235	6	CID011840957
Drug	6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A	A2M ITGA6 ARHGEF11 DDX3X QKI MMP17 CACNB1 ATN1 APBA2 TRIM3	3.88e-05	196	235	10	4833_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; HL60; HT_HG-U133A	MYO9B DDX3X MAPK8IP3 CLCN3 QKI PANK3 GPS1 GPATCH3 PLPP1 ENTPD6	4.05e-05	197	235	10	2341_DN
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A	RABEP2 KCTD13 MAPK8IP3 FASTK PLXNA1 PRKD2 WAS CTC1 BAZ1B LIMK2	4.05e-05	197	235	10	1697_DN
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	RABEP2 MAPK8IP3 MMP17 APBA2 LAMA4 PRKAR2A RORC PAX2 ATP2A1 PSD4	4.23e-05	198	235	10	5972_DN
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A	A2M ZNF318 DDX3X FLRT2 QKI PLXNA1 DUSP1 DGKE SEMA4G LIMK2	4.23e-05	198	235	10	4701_UP
Drug	Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; PC3; HT_HG-U133A	PER1 ARHGEF11 MAPK8IP3 DHODH CHAC1 CACNB1 DGKE P2RY6 LRRC8B PSD4	4.41e-05	199	235	10	4478_DN
Drug	AC1MBZ1C	PTGER4 ADCY8 SOHLH2 ATP2C2 PLEC DMPK PRKD2 LIPE P2RY6 PRKAR2A PRKG2 ATP2A1 ATP2B1 ATP2B4	5.41e-05	387	235	14	CID000003541
Disease	Ischemic stroke, fibrinogen measurement	CYP21A2 DHODH PLEC DIP2B HNF1A HECTD4	4.65e-06	55	232	6	EFO_0004623, HP_0002140
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2C2 ATP2B1 ATP2B4	9.43e-06	6	232	3	DOID:0050429 (implicated_via_orthology)
Disease	fibrinogen measurement	CYP21A2 CHKB DHODH PLEC DIP2B HNF1A DOK7	2.56e-05	109	232	7	EFO_0004623
Disease	fibrinogen measurement, tissue plasminogen activator measurement	CYP21A2 PLEC DIP2B HNF1A HECTD4	2.72e-05	45	232	5	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	CYP21A2 PLEC DIP2B HNF1A HECTD4	2.72e-05	45	232	5	EFO_0004623, EFO_0004792
Disease	mucopolysaccharidosis (implicated_via_orthology)	ARSK ARSG	6.16e-05	2	232	2	DOID:12798 (implicated_via_orthology)
Disease	cortical thickness	A2M CTTNBP2 RNLS LAMA1 ZNF318 ADGRV1 PCDH17 MAPK8IP3 STAU1 STAB1 POLR1F IGSF9 PLEC PRKAG2 ZSWIM4 PLEKHA7 ABCC10 AGAP1 AGAP3 DIP2B PRKAR2A CDH11	7.47e-05	1113	232	22	EFO_0004840
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	CYP21A2 PLEC DIP2B HNF1A HECTD4	7.93e-05	56	232	5	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	fibrinogen measurement, factor VII measurement	CYP21A2 PLEC DIP2B HNF1A HECTD4	9.39e-05	58	232	5	EFO_0004619, EFO_0004623
Disease	uric acid measurement	CYP21A2 ZNF318 ADGRV1 GGT7 VAX2 PRKAG2 PRKD2 HNF1A FRAS1 NAALAD2 HECTD4 BAZ1B SLC22A12 SLC22A3 UBASH3B	1.08e-04	610	232	15	EFO_0004761
Disease	creatinine measurement	CAPN12 RNLS CYP21A2 DGKH ADGRV1 GGT7 VAX2 PLEC BCAR3 PRKAG2 BSN RNF128 PLEKHA7 ABCC10 PRKD2 HNF1A BTAF1 TBC1D10B SLC22A3 PSD4	1.28e-04	995	232	20	EFO_0004518
Disease	Cryptophthalmos syndrome	FREM2 FRAS1	1.84e-04	3	232	2	C0265233
Disease	Epidermolysis bullosa with pyloric atresia	ITGA6 PLEC	1.84e-04	3	232	2	C1856934
Disease	FRASER SYNDROME 1	FREM2 FRAS1	1.84e-04	3	232	2	C4551480
Disease	Coats plus syndrome	CTC1 POT1	1.84e-04	3	232	2	cv:C2677299
Disease	free androgen index	CYP21A2 ZNF318 SLC51A QKI ABCC10 HNF1A DOK7 PPIF ZFHX4 SLC22A3 ATP2B4	2.00e-04	374	232	11	EFO_0007005
Disease	fibrinogen measurement, coronary artery disease	CYP21A2 DHODH DIP2B HNF1A DOK7 HECTD4 ATP2B1	2.26e-04	154	232	7	EFO_0001645, EFO_0004623
Disease	Disorder of eye	TMEM216 CDH23 ADGRV1 FREM2 USH2A TMEM126A FRAS1 PRPF8	2.90e-04	212	232	8	C0015397
Disease	Fraser syndrome (implicated_via_orthology)	FREM2 FRAS1	3.66e-04	4	232	2	DOID:0090001 (implicated_via_orthology)
Disease	toll-like receptor 2 measurement	ABCC10 TRIM3	3.66e-04	4	232	2	EFO_0020777
Disease	amino acid measurement, citrulline measurement	CYP21A2 ASPG	3.66e-04	4	232	2	EFO_0005134, EFO_0009777
Disease	non-obstructive coronary artery disease	RNF39 ATP2B1	3.66e-04	4	232	2	EFO_1001483
Disease	Usher syndrome (is_implicated_in)	USH2A ARSG	3.66e-04	4	232	2	DOID:0050439 (is_implicated_in)
Disease	pantothenate kinase-associated neurodegeneration (implicated_via_orthology)	PANK2 PANK3	3.66e-04	4	232	2	DOID:3981 (implicated_via_orthology)
Disease	level of Sterol ester (27:1/20:3) in blood serum	HNF1A DOK7 NOMO1	4.24e-04	19	232	3	OBA_2045199
Disease	myocardial infarction	CTTNBP2 FES QKI HNF1A NCKIPSD HECTD4 LAMB2 MAGI3 UNC5C ATP2B1	4.87e-04	350	232	10	EFO_0000612
Disease	chronic kidney disease (is_marker_for)	AGER POSTN PAX2	4.95e-04	20	232	3	DOID:784 (is_marker_for)
Disease	systolic blood pressure, alcohol drinking	ZNF318 FES PLEKHA7 ABCC10 HECTD4 ATP2B1	5.41e-04	128	232	6	EFO_0004329, EFO_0006335
Disease	parental longevity	CTTNBP2 CYP21A2 DHODH FES BSN HECTD4 LAMB2 MAGI3 POM121C SLC22A3 RBFOX2 PSD4	5.86e-04	494	232	12	EFO_0007796
Disease	lysine measurement, amino acid measurement	CYP21A2 ASPG	6.06e-04	5	232	2	EFO_0005002, EFO_0005134
Disease	mean arterial pressure	MYO9B ZNF318 HM13 POLR1F FES PLEKHA7 ABCC10 HECTD4 POM121C PAX2 UBASH3B ATP2B1	6.40e-04	499	232	12	EFO_0006340
Disease	reticulocyte measurement	RNLS MYO9B PER1 ADCY8 STAU1 GGT7 BSN QKI PLEKHA7 TNS3 SOWAHD HECTD4 PLEKHA4 PRPF8 PPIF UBASH3B ATP2B1 ATP2B4 ATP5F1B	7.11e-04	1053	232	19	EFO_0010700
Disease	Myasthenic Syndromes, Congenital	PLEC DOK7 LAMB2	8.60e-04	24	232	3	C0751882
Disease	diabetic encephalopathy (biomarker_via_orthology)	AGER DUSP1	9.04e-04	6	232	2	DOID:0050850 (biomarker_via_orthology)
Disease	demyelinating disease (implicated_via_orthology)	MRS2 TUBB4A	9.04e-04	6	232	2	DOID:3213 (implicated_via_orthology)
Disease	serum urea measurement	CYP21A2 ZNF318 PTGER4 PRKAG2 ABCC10 HNF1A LGR6	9.28e-04	195	232	7	EFO_0009795
Disease	blood urea nitrogen measurement	CYP21A2 DGKH ZNF318 ADGRV1 BCAR3 PRKAG2 ABCC10 HNF1A LGR6 UBASH3B PSD4	9.71e-04	452	232	11	EFO_0004741
Disease	cortical surface area measurement	RABEP2 CTTNBP2 RNLS MYO9B CYP21A2 ADGRV1 POLR1F MFAP2 FES IGSF9 PRKAG2 ZSWIM4 PLEKHA7 AGAP1 AGAP3 PRKD2 UNC5C PRKAR2A PAX2 PAX3 PCBP2 CDH11	9.98e-04	1345	232	22	EFO_0010736
Disease	cardiovascular disease	MYO9B ZNF318 CHKB FES PRKAG2 ABCC10 GRID1 UNC5C PAX2 UBASH3B ATP2B1	1.06e-03	457	232	11	EFO_0000319
Disease	COVID-19, obesity	ADCY8 ATP2A1	1.26e-03	7	232	2	EFO_0001073, MONDO_0100096
Disease	amino acid measurement, threonine measurement	CYP21A2 ASPG	1.26e-03	7	232	2	EFO_0005134, EFO_0009775
Disease	coronary artery disease	RNLS MYO9B CHKB MAPK8IP3 GGT7 FES BSN PLEKHA7 ABCC10 TNS3 PRKD2 HNF1A DOK7 HECTD4 LAMB2 MAGI3 SLC22A3 UNC5C UBASH3B ATP2B1	1.28e-03	1194	232	20	EFO_0001645
Disease	1,5 anhydroglucitol measurement	FAM83G MGAM2 PCDHA11	1.51e-03	29	232	3	EFO_0008009
Disease	chloride measurement	HNF1A ARSG SLC16A6	1.51e-03	29	232	3	EFO_0009284
Disease	Unilateral agenesis of kidney	FREM2 FRAS1	1.67e-03	8	232	2	C0266294
Disease	Ciliopathies	TMEM216 CDH23 ADGRV1 IFT43 USH2A	1.80e-03	110	232	5	C4277690
Disease	venous thromboembolism, fibrinogen measurement	CYP21A2 DIP2B HNF1A HECTD4	1.94e-03	67	232	4	EFO_0004286, EFO_0004623
Disease	urate measurement	CYP21A2 ZNF318 ADGRV1 STAB1 GNRHR2 VAX2 PRKAG2 PRKD2 HNF1A DOK7 HECTD4 BAZ1B SF1 SLC22A12 SLC22A3 RORC	2.04e-03	895	232	16	EFO_0004531
Disease	neuroimaging measurement	CTTNBP2 RNLS CYP21A2 ARHGEF11 MAPK8IP3 POLR1F IGSF9 PLEC PRKAG2 ZSWIM4 PLEKHA7 AGAP1 AGAP3 DIP2B POM121C ENTPD6 PAX3 CDH11	2.10e-03	1069	232	18	EFO_0004346
Disease	Hepatocellular Adenoma	A2M HNF1A	2.14e-03	9	232	2	C0206669
Disease	hyperuricemia	PRKD2 BAZ1B SLC22A12	2.20e-03	33	232	3	EFO_0009104
Disease	hypertension (biomarker_via_orthology)	CHGA AGER DUSP1 POSTN ENG ATP2B1 RBFOX2	2.21e-03	227	232	7	DOID:10763 (biomarker_via_orthology)
Disease	pulse pressure measurement, alcohol drinking	ZNF318 FES ABCC10 ATP2B1	2.28e-03	70	232	4	EFO_0004329, EFO_0005763
Disease	3-phenylpropionate hydrocinnamate measurement	LAMA1 AGAP1	2.66e-03	10	232	2	EFO_0021010
Disease	level of Phosphatidylcholine (18:0_22:5) in blood serum	HNF1A DOK7	2.66e-03	10	232	2	OBA_2045096
Disease	testosterone measurement	MYO9B ZNF318 CSMD3 PER3 SLC22A8 FAM186A SLC51A USH2A ABCC10 TNS3 DIP2B HNF1A DOK7 BAZ1B CWC22 LIPE ZFHX4 SLC22A3 ATP2A1 ATP2B4	2.73e-03	1275	232	20	EFO_0004908
Disease	carnitine measurement	CYP21A2 ZNF318 ABCC10 HNF1A	3.07e-03	76	232	4	EFO_0010469
Disease	glutamine measurement, amino acid measurement	CYP21A2 ASPG	3.23e-03	11	232	2	EFO_0005134, EFO_0009768
Disease	hepatocyte growth factor-like protein measurement	BSN NCKIPSD PRKAR2A	3.30e-03	38	232	3	EFO_0008154
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma	CNTNAP5 GRID1 ATP2B4	3.56e-03	39	232	3	EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354
Disease	hair colour measurement	ADGRV1 FREM2 FES BCAR3 PLXNA1 FRAS1 ASPG APBA2 TRMO BPIFB6 CATSPERB PAX3	3.65e-03	615	232	12	EFO_0007822
Disease	urate measurement, bone density	PCDH17 DDX10 CNTNAP5 VAX2 USH2A FRAS1 AHCTF1 MAGI3 GRID1 TIPARP PRKAR2A ATP2B4	3.85e-03	619	232	12	EFO_0003923, EFO_0004531
Disease	response to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent	LRRC8B RBFOX2	3.86e-03	12	232	2	GO_0097327, GO_0097328, MONDO_0009354
Disease	protein FAM3D measurement	FAM3D SLC2A6	3.86e-03	12	232	2	EFO_0021869
Disease	reticulocyte count	MYO9B ADCY8 BSN QKI PLEKHA7 TNS3 SOWAHD HECTD4 PLEKHA4 LAMA4 PRPF8 PPIF UBASH3B RNF39 ATP2B1 ATP2B4 ATP5F1B	3.92e-03	1045	232	17	EFO_0007986
Disease	Congenital small ears	FREM2 DHODH FRAS1	4.10e-03	41	232	3	C0152423
Disease	occupational attainment	KCTD12 PCDH17 AGAP1	4.39e-03	42	232	3	EFO_0020977
Disease	Schizophrenia	KCTD12 MYO9B AMACR LAMA1 CHGA ARHGEF11 FAM3D PCDH17 PANK2 AGER QKI GPS1 APBA2 GRID1 UNC5C	4.47e-03	883	232	15	C0036341
Disease	triacylglycerol 56:6 measurement	ATP2C2 AHCTF1 DOK7	4.70e-03	43	232	3	EFO_0010433
Disease	cystatin C measurement	CYP21A2 ADGRV1 HM13 PRKAG2 BSN HNF1A HECTD4 BAZ1B ENTPD6	4.76e-03	402	232	9	EFO_0004617
Disease	Antihypertensive use measurement	MYO9B ZNF318 ADCY8 ABCC10 DIP2B ATP2B1 ATP2B4	5.17e-03	265	232	7	EFO_0009927
Disease	gamma-glutamylglutamate measurement	ZNF318 ABCC10	5.26e-03	14	232	2	EFO_0021137
Disease	body fat distribution	KNTC1 MFAP2 DIP2B PAX2 PRKG2 ATP2B4	5.41e-03	202	232	6	EFO_0004341
Disease	end stage renal disease (is_marker_for)	RNLS CHGA AGER	5.68e-03	46	232	3	DOID:783 (is_marker_for)
Disease	Williams-Beuren syndrome (implicated_via_orthology)	BAZ1B LIMK2	6.04e-03	15	232	2	DOID:1928 (implicated_via_orthology)
Disease	myelodysplastic syndrome (implicated_via_orthology)	SAMD9L PRPF8	6.04e-03	15	232	2	DOID:0050908 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	CYP21A2 ARHGEF11 CSMD3 STAB1 MMP17 AMH HNF1A HECTD4 BAZ1B POM121C SEMA4G PPIF RORC PAX2 UBASH3B	6.09e-03	914	232	15	EFO_0004532
Disease	congenital left-sided heart lesions	ADCY8 FRAS1 CFAP43	6.40e-03	48	232	3	EFO_0005938
Disease	alkaline phosphatase measurement	MRS2 CYP21A2 ZNF318 PHKB RECQL4 MIEF1 ABCC10 PRKD2 HNF1A DOK7 BAZ1B ARSG PPIF SLC2A6 ENTPD6 UBASH3B	6.79e-03	1015	232	16	EFO_0004533
Disease	Diabetic Angiopathies	ADCY8 AGER	6.87e-03	16	232	2	C0011875
Disease	cystatin-F measurement	HM13 ENTPD6	6.87e-03	16	232	2	EFO_0008104
Disease	Microangiopathy, Diabetic	ADCY8 AGER	6.87e-03	16	232	2	C0025945
Disease	Calcium channel blocker use measurement	ZNF318 FES PRKAG2 ABCC10 LRPPRC ATP2B1	6.96e-03	213	232	6	EFO_0009930
Disease	glaucoma	CTTNBP2 PRKAG2 ALDH9A1 PLEKHA7 CDH11	7.55e-03	154	232	5	MONDO_0005041
Disease	mean arterial pressure, alcohol drinking	FES PLEKHA7 HECTD4 ATP2B1	7.56e-03	98	232	4	EFO_0004329, EFO_0006340
Disease	neuroimaging measurement, brain volume measurement	CTTNBP2 KCTD13 ARHGEF11 POLR1F PLEC PRKAG2 CATSPERB	7.73e-03	286	232	7	EFO_0004346, EFO_0006930
Disease	renal fibrosis (implicated_via_orthology)	AGER ENG	7.74e-03	17	232	2	DOID:0050855 (implicated_via_orthology)
Disease	serine measurement, amino acid measurement	CYP21A2 ASPG	7.74e-03	17	232	2	EFO_0005134, EFO_0009774
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DIP2B ATP2B1	7.74e-03	17	232	2	DOID:0060307 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ILNYLRDGSVPLPES	KCTD13	96	Q8WZ19
DSALPLYSLGPGERA	ADCY8	86	P40145
GQPALGPIALDDVEY	MAMDC4	1116	Q6UXC1
QSYLLLIRDEGGPPE	AGAP3	136	Q96P47
DIAGIPLPQNLSGYS	ARSK	366	Q6UWY0
PVIDPISGNALYILT	PRKAG2	386	Q9UGJ0
LLAEIYSEAGVPPGL	ALDH9A1	191	P49189
DLIYGPVLPLSAIAG	CFAP43	221	Q8NDM7
LSGGEDPIFLYPVVL	CFAP54	1301	Q96N23
QSYLLLIRDEGGPPE	AGAP1	116	Q9UPQ3
EPILGAAVYNPSGLN	CATSPERB	1001	Q9H7T0
LTGSDLPPTINAGLY	CSMD3	1136	Q7Z407
LRLDSTGVILSPGYP	CSMD3	2461	Q7Z407
PLPHIYLAELLQGGQ	CTC1	1006	Q2NKJ3
ATPQPYLGLVLEELG	CTAGE9	6	A4FU28
PYLASGDQPLERATG	CACNB1	446	Q02641
PGPRNSGVNYLILDD	BCAR3	466	O75815
ELGPLEGGYLELLNS	CIITA	26	P33076
SGLLLPDAQYPITAV	BAZ1B	621	Q9UIG0
IGRSGENPYAPLNLL	AMACR	136	Q9UHK6
GEPSGLRLQEPSLYT	COPZ2	31	Q9P299
GRILGTPDYLAPELL	MASTL	736	Q96GX5
VPLGAVDPGLLGYNV	ATN1	906	P54259
SVLYIPAGAVDPLQA	ADGRV1	556	Q8WXG9
ILPLYGDTSQRPSEG	ARHGEF11	196	O15085
GLLTPLPDLDGVYEL	DPH2	21	Q9BQC3
VILGTDYPFPLGELE	ACMSD	286	Q8TDX5
VPLERGGAEYQAVLP	ARSG	466	Q96EG1
LPLEGYVPEGLELAA	APBA2	36	Q99767
YLLPPALGLLVAAGV	DLL3	491	Q9NYJ7
LPYLSVLSGADPELG	DNHD1	3661	Q96M86
VFGLYRTLLLEPEGP	ANO9	86	A1A5B4
PEELRVYPVSGGLSN	CHKB	66	Q9Y259
DLGENGTLVYSIQPP	CDH23	806	Q9H251
TPGARLYTLLLPGLE	CDHR4	146	A6H8M9
LSDITPYQPGDLGLV	CFAP157	451	Q5JU67
SVPLGIPEGVTVLYL	FLRT2	56	O43155
DLDAVLILQGPPYVS	ENG	246	P17813
PVRPGQYDGLVELAT	ATP2A1	401	O14983
VPEGLPLAVTISLAY	ATP2B1	431	P20020
VPEGLPLAVTISLAY	ATP2B4	421	P23634
GSILGQLAVIYIPPL	ATP2C2	881	O75185
LLGRIPSAVGYQPTL	ATP5F1B	321	P06576
PVARLLIYAVLPTGD	A2M	536	P01023
QPLALEGYPSIAEGE	CCNB3	781	Q8WWL7
DSTGVPRPQIYLAGL	CFAP206	586	Q8IYR0
VALIGDQYGPCLIPS	NWD1	66	Q149M9
TPQGAVPAYLLDREG	NSA2	81	O95478
LILPEIGPQDQGTYS	AGER	286	Q15109
LPEQDIAQGSYIALP	NOMO3	1151	P69849
IPGEYLGSVLAQDPD	PCDH17	486	O14917
LEYPIEPSGVLGAVA	QKI	301	Q96PU8
LVSTGTLVPEGIYLP	RABEP2	266	Q9H5N1
GGINTYIPLISLPLV	RBFOX2	251	O43251
LLPYLQTLGGVPTQA	TIPARP	411	Q7Z3E1
YGLRPANPTEEGLAS	KIAA0895L	306	Q68EN5
SLGLQYLPDAVKGLP	ASB8	261	Q9H765
ETLNGVLSPLGPYRV	PNMA8A	41	Q86V59
LPILSQIYSDGPGEA	DDX3X	236	O00571
LDTAVELELPGYRGP	FASTK	361	Q14296
VVLAYRPGLPNALDG	ABCC10	1251	Q5T3U5
LSYELQPAAGGSRIP	PCDHA11	606	Q9Y5I1
LPEQDIAQGSYIALP	NOMO2	1151	Q5JPE7
IPGGALVLVASYDDP	FAM3D	136	Q96BQ1
QDILAGLVGYVPSVP	FRAS1	2031	Q86XX4
VLYSVPANTGLDLPV	HOGA1	166	Q86XE5
YGQLIAQGAIPPVED	LRP10	496	Q7Z4F1
PDQSIYIGAIIPLGA	MAGI3	746	Q5TCQ9
TPLNESLQPLGDYGV	MAPK8IP3	286	Q9UPT6
GILDFYIVLGPTPEL	MGAM2	1166	Q2M2H8
ILDPAISGNETQYLP	MGAM2	1271	Q2M2H8
QDVGLLRLYPGIPAA	ASPG	236	Q86U10
IGPGINTYAVDDLLP	LRIT2	411	A6NDA9
GLSAVPGDLDPLTAY	LGR6	56	Q9HBX8
LYLGELGIPLPAELE	LIMK2	606	P53671
TPDSYLGLGPQDLLA	ERN2	421	Q76MJ5
RYDAPGGAVVLPLVL	FREM2	156	Q5SZK8
GLILYEGQSRPLTGP	FREM2	446	Q5SZK8
SLPGLGQDTLVPPVY	IL17RE	391	Q8NFR9
YGLALDPIPGRQSTA	BSN	1696	Q9UPA5
ELDPLLTRTGGAYIP	CWC22	121	Q9HCG8
YDIPEGTVIIPNLQG	CYP21A2	376	P08686
GEEIPQGTYLADIPA	GPATCH3	256	Q96I76
PDIGPYGGLLNVVVD	FBXO31	151	Q5XUX0
LGYLPQDLLGAPVLL	PER1	381	O15534
AVPLLGYLPQDLIGT	PER3	291	P56645
LVDLSNPGGRPALAY	PLXNA1	461	Q9UIW2
YRPLTLNALLAVGPG	PLXNB1	1746	O43157
LLPVYELDGAPTAAQ	GGT7	461	Q9UJ14
PGGQPLCEYSTFILL	PTGER4	86	P35408
PELLSPSNVAIYGGL	GPS1	281	Q13098
LPEQDIAQGSYIALP	NOMO1	1151	Q15155
FLGLYLEGGLLPPAE	COIL	56	P38432
YSLLPLLAAAPQVGE	COIL	461	P38432
GDNVVLLYPPGIELI	DIP2B	1046	Q9P265
LSGEGQLVTYPLPFE	MRS2	171	Q9HD23
VVALLSAALALYGPP	NAXD	16	Q8IW45
VVGTPAYLAPEVLLN	PRKD2	711	Q9BZL6
LIQALGEPGPYLLAG	HNF1A	26	P20823
TPYSGPGLLIDSLVL	LAMB2	706	P55268
LPYCSLNEGDGLVLP	KNTC1	1236	P50748
AGIEPGPDTYLALLN	LRPPRC	261	P42704
LFYTRGPGPDLESLI	GDPGP1	256	Q6ZNW5
PSTPEGIALAYGSLL	HM13	26	Q8TCT9
LALLVLYPGPGPEVT	AMH	161	P03971
EGLQALGPLATYISP	MSLNL	236	Q96KJ4
DESLVPVPANSYLGL	ITGA6	246	P23229
ISYLEAGVLPSALNP	MIEF1	416	Q9NQG6
LVLYPALGPEGSALF	PCDHGB3	561	Q9Y5G1
YAAPGPRGIIINLEN	CLPS	16	P04118
ECDGQYIPLPSLQGI	DGKH	831	Q86XP1
GGIPRDLYLPTIEDI	HECTD4	2306	Q9Y4D8
GDLAQPLAAPAGYLT	SLC2A6	381	Q9UGQ3
AVGTPDYLSPEILQA	DMPK	231	Q09013
DYLSPEILQAVGGGP	DMPK	236	Q09013
LGILVYELLTGNPPF	PRKG2	636	Q13237
VIQALPVPGLAAAYD	IRGC	276	Q6NXR0
IGNYLETLPPELEGC	LRRC8B	756	Q6P9F7
EQGNEYSLPALTPGL	PAX2	286	Q02962
PQTDYALSPLTGGLE	PAX3	406	P23760
DLEGPPLEAYTIQGQ	PCBP2	221	Q15366
DPYPLLVVNIGSGVS	PANK3	181	Q9H999
PPQLGYSITAEDLDL	POM121C	501	A8CG34
SPGSQINVLEDPGYL	PPM1E	556	Q8WY54
LVGLFLVPDGIYDPA	SLC51A	196	Q86UW1
NPYPLLLVNIGSGVS	PANK2	381	Q9BZ23
PALYGLVLVVGLPAN	F2RL3	81	Q96RI0
PLPSEILGPVEQYLG	NLGN4Y	61	Q8NFZ3
GVPALLSPELLYALA	FUOM	6	A2VDF0
VLLSTPAPLYGGLAL	DUOXA2	196	Q1HG44
LQGPYLPLELGLEQL	CAPN12	541	Q6ZSI9
GLVLPLAYGFQPDLV	HDAC10	561	Q969S8
LNGSDYGGDIPIIPD	IFT43	91	Q96FT9
IQASYEPLGISLRPL	BCL6B	131	Q8N143
SVTYLRLDGSIPPGQ	BTAF1	1671	O14981
APSGILDVTVVYLNP	CCNF	631	P41002
YLIIALLNATPGPDV	GCFC2	681	P16383
QGGPVEILPFLYLGS	DUSP1	171	P28562
PLRISVGEIEPSNYG	CTTNBP2	971	Q8WZ74
GYLGPAPEEAIATQI	CHAC1	151	Q9BUX1
DLYLLPIVISDGGIP	CDH11	566	P55287
TLGGVYHLDILELPP	DNAI7	381	Q6TDU7
PEGYAKGSSQLLLPA	BPIFB6	246	Q8NFQ5
LISGPGVDEYPEIGL	CDH26	91	Q8IXH8
SLPRGNYLVPLFIGD	CDH26	566	Q8IXH8
GGLAPTQTLEPTREY	GRID1	906	Q9ULK0
IPPGLTELLQGYTVE	PRKAR2A	6	P13861
SGPSLNELIPDGYNR	AHCTF1	506	Q8WYP5
PEYALSLGLAVAPRV	DDX10	496	Q13206
YIPQVAVLPLGTGND	DGKE	301	P52429
EPGLPYEGLVHTLAI	DOK7	66	Q18PE1
QLGGYPDIPRLLQLE	FAM186A	2316	A6NE01
VQLSLPSTLYLGGLP	CA14	86	Q9ULX7
PFIPNIIYGITALLG	SLC22A8	471	Q8TCC7
LPLLVYGTVPVLSGL	SLC22A12	496	Q96S37
ANSLESVGPIDYVLP	INPP5F	876	Q9Y2H2
TLGIIILPGIAYFIP	SLC22A3	251	O75751
YLSGVGLFPQPLDTE	CFAP47	2736	Q6ZTR5
QGGPVEILPFLYLGS	DUSP5	176	Q16690
ILAELLTGYPLLPGE	DYRK2	411	Q92630
LLPLGYSEPEQQEGA	KCTD12	156	Q96CX2
LDIDYELSFGGIPVP	CNTNAP5	301	Q8WYK1
SYLLLPGTPQIDGLS	CNTNAP5	376	Q8WYK1
LPAGLLAQGQYDLDP	MFAP2	11	P55001
GGDKPALDLYQLSPS	PHKB	891	Q93100
TGPGPVLVRLISYDL	LIPE	596	Q05469
QLLLPPVYSAVLAAG	P2RY6	26	Q15077
PVYSAVLAAGLPLNI	P2RY6	31	Q15077
TDIYIGGAPPEILQS	LAMA4	1171	Q16363
PSLYIIPLGISLGID	SLC16A6	311	O15403
AVGNVLIIPAIYSDP	OR1L6	76	Q8NGR2
GELLGEYPGIPELSA	TESMIN	91	Q9Y4I5
PGSDILGYINIIDPN	FAM83G	421	A6ND36
NLYRLEGEGFPSIPL	FES	511	P07332
DPALYLPARGALDGT	FREM3	41	P0C091
LVPPALQSYLGTDRI	SARS2	476	Q9NP81
TSLPLPGYLEQGIAT	AK9	1796	Q5TCS8
GVPEGNLTLSYIIPI	USH2A	1146	O75445
VNPELTAGPITGLVY	TRIM43	266	Q96BQ3
VEHPLLSGLLYPGLQ	YARS1	156	P54577
LDVAPYIGLPANASL	TRNT1	261	Q96Q11
PPGYEVVSLLEALNG	RNF157	361	Q96PX1
PASIGLLSPGILEYL	RSPRY1	216	Q96DX4
LYPVFLAIPVNGGLA	TMEM126A	116	Q9H061
TILPEDGGPYTNSIL	TMEM132B	1031	Q14DG7
EGTLQASPPGYLTAL	ENTPD6	266	O75354
LYTQIPGLYGPEGIL	LMF2	26	Q9BU23
SIPSGYLELPDLGQP	NBPF19	1421	A0A087WUL8
VLDGELEVAPGYPQS	MMP17	501	Q9ULZ9
LGSVLLPSYNIRPDG	PLEKHA4	96	Q9H4M7
LPLYSLGPSGQLAET	RECQL4	451	O94761
YTLQPETGALNLIDP	SAMD9L	181	Q8IVG5
NIPVIPGGYLQTLLD	NEXMIF	806	Q5QGS0
LSLNLTGIIPVPYGI	LAMA1	1576	P25391
TGIIPVPYGILSNLE	LAMA1	1581	P25391
LGLLNAPLDPLLYGA	GNRHR2	221	Q96P88
EDTIPYALLGGIIIP	PLPP1	51	O14494
PSSVAEALGIVPLQY	POT1	526	Q9NUX5
ILNLYLGDSLEPHPG	PSD4	16	Q8NDX1
LGPLADYLVVNVSSP	DHODH	201	Q02127
SLGLVGPESRYQTLP	PLEKHA7	1001	Q6IQ23
YGQDSPLEPVAGVLV	RNF128	71	Q8TEB7
IGQVPALLESELYPA	SPATA32	66	Q96LK8
LVLDILQDYPGLPGL	SLC5A8	326	Q8N695
PLVYLDVDANGKPLG	PPIF	46	P30405
SGGVPLVQAPYTVLL	SAPCD1	6	Q5SSQ6
GLAFALLVDIPPVYG	SLC26A3	91	P40879
EPELLLRGDPITGYS	SOWAHD	136	A6NJG2
PGYPQDLDIIDGRIL	TNS3	821	Q68CZ2
ADGGLYQIPLPSSQI	NCKIPSD	156	Q9NZQ3
APTPGSLLEAYVINV	SNED1	1126	Q8TER0
PLVLYQSDILQTPDG	ABHD1	86	Q96SE0
DSLEAGLPLQVRGYP	CHGA	401	P10645
LLDLLDEPIPGVGTY	CLCN3	71	P51790
PSPTGVLIAIDLAYN	PRPF8	1696	Q6P2Q9
SAGLGILAPSETYPL	TBX10	6	O75333
PALETGNLLTEPVGY	TRMO	21	Q9BU70
AAALAPGLGELSPYI	ZFHX4	856	Q86UP3
TLTYTLGLPDGQLPL	RORC	146	P51449
SLYVGAPSGVIQLPL	SEMA4G	491	Q9NTN9
PVPPLLYQVELSVGG	STAU1	121	O95793
LAYGVLRPLSSPIEG	RNLS	81	Q5VYX0
GGNYVPRAVLVDLEP	TUBB4A	56	P04350
GQLPSSLDTLPGYEE	TMEM52B	126	Q4KMG9
LATAVVQLYLALPPG	WAS	46	P42768
LAYGIDQLLEPPGLG	STAB1	1856	Q9NY15
ISGPRGQAPDTLSYL	TBC1D10B	256	Q4KMP7
GQAGVLPCLELPTYA	POLR1F	21	Q3B726
EVQYLTGGLIEPDTP	PLEC	4526	Q15149
SGLEVYPSRTQLPGL	IGSF9	716	Q9P2J2
EEQDLIGPVVALGYP	UBAP1L	271	F5GYI3
GELQEPGLPGVLSYV	ZNF415	16	Q09FC8
SSAPLLDLPAGYELG	VAX2	251	Q9UIW0
VNPELTAGPITGLVY	TRIM43B	266	A6NCK2
PYEDQGLGETTPLTI	UBASH3B	351	Q8TF42
ALRPDGEYTLLAPVN	POSTN	396	Q15063
GPEELGLPLQRSYSE	SOHLH2	151	Q9NX45
GVLLPYPTANLVLDV	TMEM216	46	Q9P0N5
SLLIPAGAIPQGRVY	UNC5C	551	O95185
GLERYISQEEGPLSP	ZNF318	201	Q5VUA4
EYPEINFVGLLIGPR	SF1	146	Q15637
GYGGLLVELSPLFPD	METTL1	86	Q9UBP6
INTSAEPLYGPQGLA	TRIM3	706	O75382
LLYAFQAPGPLGERI	RNF39	386	Q9H2S5
PGSPGESYLVLALEV	ZSWIM4	456	Q9H7M6
LPPDLVNVRGYGSAI	KLHL42	236	Q9P2K6
DAEILLRYLGGIAPP	NAALAD2	291	Q9Y3Q0
YITPGADLPVQGALE	MYO9B	2111	Q13459